1. Academic Validation
  2. Development of an orally bioavailable selective inhibitor of the menin-MLL

Development of an orally bioavailable selective inhibitor of the menin-MLL

  • Genes Dis. 2022 Oct 18;10(5):1735-1738. doi: 10.1016/j.gendis.2022.10.005.
Hai-Jing Zhong 1 2 3 Wanhe Wang 4 Wei Zhou 2 Jia-Xin Liang 1 Yung-Chi Cheng 2 Dik-Lung Ma 4 Chung-Hang Leung 1 5
Affiliations

Affiliations

  • 1 State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
  • 2 Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
  • 3 International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou, Guangdong 510632, China.
  • 4 Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China.
  • 5 Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Macao SAR, China.
Figures
Products